Literature DB >> 27327286

Endophthalmitis Associated With Glaucoma Drainage Implants.

Carlos A Medina, Michelle R Butler, Avnish A Deobhakta, Michael R Banitt, Thomas A Albini, William E Smiddy, Audina M Berrocal, Steven J Gedde, Harry W Flynn.   

Abstract

BACKGROUND AND
OBJECTIVE: To identify the clinical features, organisms, and treatment outcomes in patients with endophthalmitis associated with glaucoma drainage implants. PATIENTS AND METHODS: A retrospective noncomparative case series.
RESULTS: Of the 13 patients, exposure occurred in eight eyes, including exposure of the tube in four eyes, exposure of the patch graft in three eyes, and exposure of the plate in one eye. In the remaining five eyes, either recent implant placement or conjunctival revision occurred. The most common organism was Staphylococcus epidermidis (five eyes). Intravitreal antibiotics were administered in all eyes, with the exception of one eye (primary evisceration). Removal of the implant was performed in six eyes and evisceration or enucleation was performed in three eyes. Median pre-infection visual acuity was 20/80 (range: 20/30 to hand motion). Visual acuity at last follow-up was no light perception (five eyes), light perception (two eyes), hand motion (one eye), and better than or equal to 20/200 (five eyes).
CONCLUSION: Clinical features associated with endophthalmitis include implant exposure and a history of recent surgery. Staphylococcus epidermidis was the most common isolate. Although removal of the implant was performed in many patients, successful treatment was accomplished in some patients without removal. Visual outcomes were generally poor. [Ophthalmic Surg Lasers Imaging Retina. 2016;47:563-569.]. Copyright 2016, SLACK Incorporated.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27327286     DOI: 10.3928/23258160-20160601-08

Source DB:  PubMed          Journal:  Ophthalmic Surg Lasers Imaging Retina        ISSN: 2325-8160            Impact factor:   1.300


  7 in total

1.  Viscocanalostomy combined with trabeculotomy and mitomycin C in the treatment of primary congenital glaucoma.

Authors:  Chao-Xu Qian; Yuan Zong; Qin Chen; Zhi-Lan Yuan
Journal:  Int J Ophthalmol       Date:  2017-06-18       Impact factor: 1.779

Review 2.  Endophthalmitis: Then and Now.

Authors:  Nidhi Relhan; Richard K Forster; Harry W Flynn
Journal:  Am J Ophthalmol       Date:  2017-12-05       Impact factor: 5.258

3.  Outcomes of the Shunt Tube Exposure Prevention Study: A Randomized Clinical Trial.

Authors:  Hosam Sheha; Celso Tello; Lama A Al-Aswad; Mohamed S Sayed; Richard K Lee
Journal:  Ophthalmol Glaucoma       Date:  2019-08-16

Review 4.  Management of endophthalmitis related to glaucoma drainage devices: review of the literature and our experience.

Authors:  Yasmin Florence Khodeja Islam; Charles Richard Blake; Syed Khurshid Gibran
Journal:  Eye (Lond)       Date:  2021-03-05       Impact factor: 4.456

Review 5.  Nontuberculous mycobacterial endophthalmitis: case series and review of literature.

Authors:  Warinyupa Pinitpuwadol; Nattaporn Tesavibul; Sutasinee Boonsopon; Darin Sakiyalak; Sucheera Sarunket; Pitipol Choopong
Journal:  BMC Infect Dis       Date:  2020-11-23       Impact factor: 3.090

Review 6.  Practical Guidance for Clinical Microbiology Laboratories: Diagnosis of Ocular Infections.

Authors:  Sixto M Leal; Kyle G Rodino; W Craig Fowler; Peter H Gilligan
Journal:  Clin Microbiol Rev       Date:  2021-06-02       Impact factor: 50.129

7.  Patch Grafting Using an Ologen Collagen Matrix to Manage Tubal Exposure in Glaucoma Tube Shunt Surgery.

Authors:  Masaki Tanito; Ichiya Sano; Yoshifumi Ikeda; Etsuko Fujihara
Journal:  Case Rep Ophthalmol       Date:  2018-01-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.